Mental health economics: Current methodological issues

Epidemiology and Psychiatric Sciences

Volumn 20, Issue 3, 2011, Pages 239-243

  McCrone, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

cost effectiveness analysis; costs; economics; mental health services; QALYS

Indexed keywords

ECONOMICS; HEALTH CARE COST; HUMAN; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; REVIEW;

HEALTH CARE COSTS; HUMANS; MENTAL DISORDERS; MENTAL HEALTH; MENTAL HEALTH SERVICES; QUALITY-ADJUSTED LIFE YEARS;

EID: 80053073987     PISSN: 20457960     EISSN: 20457979     Source Type: Journal    
DOI: 10.1017/S2045796011000485     Document Type: Article

References (21)

1. Al-Janabi H, Coast J (2009). ICECAP-A: Developing a Measure of an Adult's Capabilities Health Economics Unit, University of Birmingham: Birmingham. http://www.pronewsletter.com/images/PDF-articles/icecap-a-final.pdf
2. Amaddeo F, Beecham J, Bonizzato P, Fenyo A, Knapp M, Tansella M (1997). The use of a case register to evaluate the costs of psychiatric care. Acta Psychiatrica Scandinavica 95, 189-198. (Pubitemid 27140289)
3. Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D (2009). Measuring the benefits of treatment for psychosis: the validity and responsiveness of the EQ-5D. British Journal of Psychiatry 195, 170-177.
4. Beecham J, Knapp M (2001). Costing psychiatric interventions. In Measuring Mental Health Needs (ed. G Thornicroft), pp. 200-224. Gaskell: London.
5. Brazier J (2010). Is the EQ-5D fit for purpose in mental health? British Journal of Psychiatry 197, 348-349.
6. Brazier JE, Roberts JF, Deverill MD (2002). The estimation of a preference based measure of health from the SF-36. Journal of Health Economics 21, 271-292.
7. Byford S, Torgerson DJ, Raftery J (2000). Cost of illness studies. British Medical Journal 320, 1335.
8. Byford S, Leese M, Knapp M, Seivewright H, Cameron S, Jones V, Davidson K, Tyrer P (2007). Comparison of alternative methods of collection of service use data for the economic evaluation of health care interventions. Health Economics 16, 531-536. (Pubitemid 46784286)
9. Calsyn RJ, Allen G, Morse GA, Smith R, Tempelhoff B (1993). Can you trust self-report data provided by homeless mentally ill individuals? Evaluation Review 17, 353-366.
10. Goldberg RW, Seybolt DC, Lehman A (2002). Reliable self-report of health service use by individuals with serious mental illness. Psychiatric Services 53, 879-881. (Pubitemid 34742772)
11. Knapp M, Mangalore R, Simon J (2004). The global costs of schizophrenia. Schizophrenia Bulletin 30, 279-293. (Pubitemid 38828535)
12. Knapp M, Windmeijer F, Brown J, Kontodimas S, Tzivelekis S, Haro JM, Ratcliffe M, Hong J, Novick D (2008). Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO study. Pharmacoeconomics 26, 341-358. (Pubitemid 351457480)
13. Koopmanschap MA, Ineveld BMV (1992). Towards a new approach for estimating indirect costs of disease. Social Science and Medicine 9, 1005-1010.
14. Koopmanschap MA, van Exel JN, van den Berg B, Brouwer WB (2008). An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics 26, 269-280. (Pubitemid 351790246)
15. McCrone P, Dhanasiri S, Patel A, Knapp M, Lawton-Smith S (2008). Paying the Price: the Cost of Mental Health Care in England to 2026. King's Fund: London.
16. McCrone P, Patel A, Knapp M, Schene A, Koeter M, Amaddeo F, Ruggeri M, Giessler A, Puschner B, Thornicroft G (2009). A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia. Journal of Mental Health Policy and Economics 12, 27-31.
17. National Institute for Health and Clinical Excellence (2008). Guide to the Methods of Technology Appraisal. NICE: London.
18. Patel A, Rendi A, Moran P, Leese M, Mann A, Knapp M (2005). A comparison of two methods of collecting economic data in primary care. Family Practice 22, 323-327. (Pubitemid 40744513)
19. Sabes-Figuera R, Razzouk D, McCrone P (2010). Economics of bipolar disorder. In Bipolar Disorder: Clinical and Neurobiological Foundations (ed. LN Yatham and M Maj), pp. 90-95. Wiley-Blackwell: Chichester.
20. Williams A (1995). The Role of the EUROQOL Instrument in QALY Calculations. Centre for Health Economics, University of York: York.
21. World Health Organisation (2008). Global Burden of Disease 2004 Update. World Health Organisation: Geneva.